Peroxiredoxin I protein, a potential biomarker of hydronephrosis in fetal mice exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Mingxue Liu, Jing Liu, Xing Liu, Guanghui Wei
Index: J. Pediatr. Urol. 10(3) , 474-81, (2014)
Full Text: HTML
Abstract
In previous studies, we established an animal model of human congenital hydronephrosis with exposure of developing mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), but the etiopathogenesis is not entirely clear. The present study was to identify the changes that may be involved in the etiology at the protein level.C57BL/6J mice fetuses were treated with TCDD. Comparative proteomic analysis was adopted to identify the proteins associated with hydronephrosis induced by TCDD.Two-dimensional electrophoresis display revealed that 19 protein spots were differentially expressed in the upper urinary tract tissues in fetal mice after exposure to TCDD. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) identified 12 up-regulated proteins: peroxiredoxin I (Prx I), cadherin 6, gamma-actin, radixin, desmin, type II transforming growth factor-beta receptor, chromogranin B, serum albumin precursor, transferrin, hypothetical protein LOC70984, lipk protein, and zinc finger protein 336. Histochemical staining indicated that Prx I protein was positively expressed in the ureteric epithelium in the treated group, and not in the control group, which is consistent with MALDI-TOF-MS.Prx I protein may be a potential biomarker or responsive protein of hydronephrosis in fetal mice induced by TCDD.Copyright © 2013 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2014-09-26
[J. Chromatogr. A. 1361 , 265-76, (2014)]
2015-02-01
[Biochim. Biophys. Acta 1848(2) , 712-20, (2014)]
Kafirin adsorption on ion-exchange resins: isotherm and kinetic studies.
2014-08-22
[J. Chromatogr. A. 1356 , 105-16, (2014)]
2014-01-01
[Int. Arch. Allergy Immunol. 165(2) , 83-90, (2014)]
Stability of collapse lyophilized influenza vaccine formulations.
2015-04-10
[Int. J. Pharm. 483(1-2) , 131-41, (2015)]